Tracon Pharmaceuticals, Inc. (TCON)

Last Year

20-Apr-23 -- 19-Apr-24

Time Period:

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Biotechnology

Drugs

Insider Trading Sentiment: Reduce

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

28

0

1

+1

0

+2

0

+3

Two Year Chart

20-Apr-22 -- 19-Apr-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
13-Mar-24 5:56 PM View:	20-Oct-23 Grant $0.47K	Theuer Charles President and CEO Director		Tracon Pharmaceuticals, Inc. - TCON	2% 399.42K to 406.42K	0	0	--	--	Show Txns Hide Txns

14-Nov-23 10:00 PM View:	10-Nov-23 Sale ($1.40M)	Opaleye Management Inc. 10% Owner		Tracon Pharmaceuticals, Inc. - TCON	(100%) 4.76M to 0	0	0	--	--	Show Txns Hide Txns

13-Mar-24 5:59 PM View:	20-Apr-23 Grant $0.48K	Brown Scott B. Chief Financial Officer		Tracon Pharmaceuticals, Inc. - TCON	16% 21.63K to 25.13K	0	0	--	--	Show Txns Hide Txns